<DOC>
	<DOCNO>NCT01786668</DOCNO>
	<brief_summary>This first study oral tofacitinib adult active ankylose spondylitis . It design obtain information efficacy safety 3 different dos tofacitinib .</brief_summary>
	<brief_title>Dose-Ranging Study Of Tofacitinib In Adults With Active Ankylosing Spondylitis</brief_title>
	<detailed_description />
	<mesh_term>Spondylitis</mesh_term>
	<mesh_term>Spondylitis , Ankylosing</mesh_term>
	<mesh_term>Tofacitinib</mesh_term>
	<criteria>Documented diagnosis Ankylosing Spondylitis Has active disease despite concurrent nonsteroidal antiinflammatory drug ( NSAIDs ) treatment intolerant NSAIDs Pregnant lactate female Currently receive previous use Tumor Necrosis Factor ( TNF ) inhibitor biological agent</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2016</verification_date>
	<keyword>Ankylosing Spondylitis</keyword>
	<keyword>Spondylitis</keyword>
	<keyword>Ankylosing</keyword>
	<keyword>Spondyloarthritis</keyword>
	<keyword>Spondyloarthropathy</keyword>
	<keyword>Oral preparation</keyword>
</DOC>